Background Tranexamic acid (TXA) reduces surgical bleeding and reduces death from
bleeding after trauma and childbirth. However, its effects on thrombotic events and seizures …

Despite over a half-century of recognizing fibrinolytic abnormalities after trauma, we remain
in our infancy in understanding the underlying mechanisms causing these changes …

Objective: We sought to characterize the timing of administration of prehospital tranexamic
acid (TXA) and associated outcome benefits. Background: TXA has been shown to be safe …

Background Women are less likely than men to receive some emergency treatments. This
study examines whether the effect of tranexamic acid (TXA) on mortality in trauma patients …

Objective We evaluated the efficacy of topical application of the injectable form of tranexamic
acid (TXA) compared with anterior nasal packing (ANP) for the treatment of epistaxis in …

BACKGROUND The association between tranexamic acid (TXA) and fibrinolysis shutdown
is unknown. We hypothesize that TXA is associated with fibrinolysis shutdown in critically …

Tranexamic acid is used both pre‐hospital and in‐hospital as an antifibrinolytic drug to treat
or prevent hyperfibrinolysis in trauma patients; dosing, however, remains empirical. We …

BACKGROUND In the Study of Tranexamic Acid During Air and Ground Prehospital
Transport (STAAMP) Trial, prehospital tranexamic acid (TXA) was associated with lower …

Tranexamic acid (TXA) is one of the measures indicated to reduce bleeding and the need for
volume replacement. However, data on risks and benefits are controversial. This study …

Introduction Tranexamic acid (TXA) is one of the debated therapies in the management of
traumatic brain injury (TBI). We conducted this study to evaluate the benefits of TXA in TBI on …